Wiley Jenny L, Marusich Julie A, Thomas Brian F
RTI International, 3040 Cornwallis Road, Research Triangle Park, NC, 27709-2194, USA.
Curr Top Behav Neurosci. 2017;32:231-248. doi: 10.1007/7854_2016_17.
Originally developed as research tools for use in structure-activity relationship studies, synthetic cannabinoids contributed to significant scientific advances in the cannabinoid field. Unfortunately, a subset of these compounds was diverted for recreational use beginning in the early 2000s. As these compounds were banned, they were replaced with additional synthetic cannabinoids with increasingly diverse chemical structures. This chapter focuses on integration of recent results with those covered in previous reviews. Whereas most of the early compounds were derived from the prototypic naphthoylindole JWH-018, currently popular synthetic cannabinoids include tetramethylcyclopropyl ketones and indazole-derived cannabinoids (e.g., AB-PINACA, AB-CHMINACA). Despite their structural differences, psychoactive synthetic cannabinoids bind with high affinity to CB receptors in the brain and, when tested, have been shown to activate these receptors and to produce a characteristic profile of effects, including suppression of locomotor activity, antinociception, hypothermia, and catalepsy, as well as Δ-tetrahydrocannabinol (THC)-like discriminative stimulus effects in mice. When they have been tested, synthetic cannabinoids are often found to be more efficacious at activation of the CB receptor and more potent in vivo. Further, their chemical alteration by thermolysis during use and their uncertain stability and purity may result in exposure to degradants that differ from the parent compound contained in the original product. Consequently, while their intoxicant effects may be similar to those of THC, use of synthetic cannabinoids may be accompanied by unpredicted, and sometimes harmful, effects.
合成大麻素最初是作为用于构效关系研究的研究工具而开发的,为大麻素领域的重大科学进展做出了贡献。不幸的是,从21世纪初开始,这些化合物中的一部分被转用于娱乐用途。随着这些化合物被禁止,它们被具有越来越多样化化学结构的其他合成大麻素所取代。本章重点是将近期结果与先前综述中涵盖的结果进行整合。虽然大多数早期化合物源自原型萘甲酰吲哚JWH-018,但目前流行的合成大麻素包括四甲基环丙基酮和吲唑衍生的大麻素(例如,AB-PINACA、AB-CHMINACA)。尽管它们在结构上存在差异,但具有精神活性的合成大麻素与大脑中的CB受体具有高亲和力,并且在测试时已显示出激活这些受体并产生特征性的效应谱,包括抑制运动活性、抗伤害感受、体温过低和僵住症,以及在小鼠中产生类似Δ-四氢大麻酚(THC)的辨别刺激效应。在进行测试时,合成大麻素通常在激活CB受体方面更有效,并且在体内更具效力。此外,它们在使用过程中通过热解发生的化学变化以及其不确定的稳定性和纯度可能导致接触到与原始产品中所含母体化合物不同的降解产物。因此,虽然它们的中毒效应可能与THC相似,但使用合成大麻素可能会伴随着不可预测的、有时甚至是有害的效应。